Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age
NCT ID: NCT05433519
Last Updated: 2024-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2022-07-27
2023-11-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Zambian Preterm Birth Prevention Study
NCT02738892
Sonographic Evaluation of Fetal Growth in the Third Trimester of Low-risk Pregnancy: a Randomized Trial
NCT03200665
Early Pregnancy Evaluation by Three-Dimensional Ultrasound
NCT00342290
Protein and Ultrasound Indicators of Preterm Birth
NCT01412931
A Follow-up of the Early Pregnancy Study Cohort.
NCT01132924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant Women
Pregnant women with gestational age established at less than 14 weeks of gestation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* viable intrauterine pregnancy at less than 14 0/7 weeks of gestation
* ability and willingness to provide written informed consent
* intent to remain in current geographical area of residence for the duration of study
* willingness to adhere to study procedures
Exclusion Criteria
* multiple gestation (i.e., twins or higher order)
* major fetal malformation or anomaly
* any other condition (social or medical) that, in the opinion of the study staff, would make study participation unsafe or complicate data interpretation.
18 Years
59 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bill and Melinda Gates Foundation
OTHER
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeff Stringer, MD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina
Chapel Hill, North Carolina, United States
University Teaching Hospital
Lusaka, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Stringer JSA, Pokaprakarn T, Prieto JC, Vwalika B, Chari SV, Sindano N, Freeman BL, Sikapande B, Davis NM, Sebastiao YV, Mandona NM, Stringer EM, Benabdelkader C, Mungole M, Kapilya FM, Almnini N, Diaz AN, Fecteau BA, Kosorok MR, Cole SR, Kasaro MP. Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps. JAMA. 2024 Aug 27;332(8):649-657. doi: 10.1001/jama.2024.10770.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-3115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.